FDA: More Contaminants Found in Recalled Valsartan Heart Drugs

Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:

A brand of recalled heart failure and blood pressure medication was found to have a second, carcinogenic impurity.

The U.S. Food and Drug Administration (FDA) said that three lots of Torrent Pharmaceuticals’ valsartan drugs have NDEA, known to cause cancer in animals and is believed to be carcinogenic to humans, according to a statement on Sept. 13.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics